The damages phase of Abbott Laboratories’ patent suit against
Arterial Vascular Engineering, Inc. (now known as Medtronic
Vascular, Inc.) awaits the outcome of Medtronic’s appeal to the
infringement and validity…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.